CEO & Founder, Ketim Therapeutics
BIOGRAPHY
Speaker
Event Date & Time
Date: January 30, 2025
Time: 1:00 PM (PST), 4:00 PM (EST), (January 31) 7:00 AM (BNE)
Abstract
In this webinar, Dr. Clarissa Yates, CEO of Ketim Therapeutics, will share her exciting results from a proteomics pilot study exploring biomarkers associated with postpartum depression (PPD) using Olink Explore HT. This research investigated a cohort of 50 mothers diagnosed with PPD, focusing on discovering proteins that may serve as unique biomarkers for early detection and treatment response monitoring of PPD. This session delves into the complex biological underpinnings of PPD. It showcases how affinity-based proteomic profiling technology, with comprehensive library design and robust analytical performance, can advance our understanding of mental health challenges during the perinatal period. It will also explore the potential of biomarker-driven solutions in transforming mental health care.
Learning Objectives
- Understand protein biomarkers' critical role in advancing our mental health knowledge.
- Learn how cutting-edge proteomic technologies, such as Olink Explore HT, are utilized to identify and analyze protein biomarkers linked to postpartum depression (PPD).
- Discuss how precision and personalized approaches can revolutionize mental health care, with a focus on supporting new mothers
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
Loading Comments...